Pfizer's Moonshot

The diabetes drugs that transformed weight loss may be key to treating addiction, too. Dr. Sanjay Gupta speaks with Dr. Dhruv Khullar about how GLP-1s affect the brain, its reward system, and maybe even addiction. This episode was produced by Jennifer Lai with assistance from Sof ...  Show more

An FDA panel has recommended allowing compounding pharmacies to make six unapproved peptides. Dr. Sanjay Gupta and CNN Health's John Bonifield discuss their popularity, safety concerns and what comes next. This episode was produced by Madeleine Thompson and Leying Tang. Medical W ...  Show more

Most of us were blindsided by the novel virus SarsCov2, but infectious disease experts had been warning about the possibility of a global pandemic for some years. For them it was never a matter of if, but when. What did come as a surprise was the speed of scientific progress to f ...  Show more

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.

But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ...

As COVID-19 spread, BioNTech cofounders Uğur Şahin and Özlem Türeci had one goal: to make a safe, effective vaccine faster than ever before. In this illuminating conversation with head of TED Chris Anderson, the immunologists (and married couple) share the fascinating story of ho ...  Show more

The two mRNA Covid vaccines are the first vaccines to come out of a new field of immunology and represent such an amazing leap forward that they are taking us into a new era of medicine. Learn all about them so you can set your uncle straight.